Butalbital, Acetaminophen And Caffeine 70752-0141-14
- Manufacturer
- Quagen Pharmaceuticals Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- August 6, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA216376
Active Ingredients
| Ingredient | Strength |
|---|---|
| Acetaminophen | 325 mg/1 |
| Butalbital | 50 mg/1 |
| Caffeine | 40 mg/1 |
Drug Class
Barbiturate [EPC]Central Nervous System Stimulant [EPC]Methylxanthine [EPC]
Selected Package
70752-0141-14Selected500 CAPSULE in 1 BOTTLE, PLASTIC (70752-141-14)
Other packages for this product(1)
100 CAPSULE in 1 BOTTLE, PLASTIC (70752-141-10)